Rosuvastatin and vitamin D: Might there be hypovitaminosis D on JUPITER?

International Journal of Cardiology

Volumn 145, Issue 3, 2010, Pages 556-557

  Goldstein, Mark R ^a   Mascitelli, Luca ^b   Pezzetta, Francesca ^c  

^a Fountain Medical Court ^*  (United States)

^b Medical Service   (Italy)

^c Ospedale Civile di Tolmezzo   (Italy)

Author keywords

C reactive protein; Primary prevention; Rosuvastatin; Vitamin D

Indexed keywords

ATORVASTATIN; C REACTIVE PROTEIN; COLECALCIFEROL; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; ROSUVASTATIN; VITAMIN D;

ANTINEOPLASTIC ACTIVITY; CALCIUM HOMEOSTASIS; CANCER MORTALITY; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CELL PROLIFERATION; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; HUMAN; IMMUNOMODULATION; LETTER; MORTALITY; MYALGIA; MYOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; TREATMENT DURATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 78649967367     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.05.022     Document Type: Article

References (31)

1. P.M. Ridker, E. Danielson, F.A.H. Fonseca for the JUPITER Study Group Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2008 2195 2207
2. P.M. Ridker, V.E. Friedewald, M.H. Davidson, J.T. Willerson, and W.C. Roberts The Editor's roundtable: the JUPITER Trial-initial results and clinical implications Am J Cardiol 103 2009 1417 1425
3. M. Petretta, P. Costanzo, P. Perrone-Filardi, and M. Chiariello Impact of gender in primary prevention of coronary heart disease with statin therapy: a meta-analysis Int J Cardiol 138 2010 25 31
4. M.F. Holick High prevalence of vitamin D inadequacy and implications for health Mayo Clin Proc 81 2006 353 373
5. A. Zitterman, S.S. Schleithoff, and R. Koerfer Putting cardiovascular disease and vitamin D insufficiency into perspective Br J Nutr 94 2005 483 492
6. R. Kazlauskaite, L.H. Powell, C. Mandapakala, J.F. Cursio, E.F. Avery, and J. Calvin Vitamin D is associated with atheroprotective high-density lipoprotein profile in postmenopausal women J Clin Lipidol 4 2010 113 119
7. I. Cantor Shedding light on vitamin D and integrative oncology Integr Cancer Ther 7 2008 81 89
8. F. Baeke, C. Gysemans, H. Korf, and C. Mathieu Vitamin D insufficiency: implications for the immune system Pediatr Nephrol Feb 24, 2010 Electronic publication ahead of print
9. D.S. Grimes Statins and vitamin D Cardiovasc Drugs Ther 23 2009 261 262
10. D.T. Ertugrul, B. Yavuz, and H. Cil Comparison of the influences of rosuvastatin and fluvastatin treatment on the levels of 25 hydroxyvitamin D Cardiovasc Ther Mar 27, 2010 Electronic publication ahead of print
11. J.L. Pérez-Castrillón, G. Vega, and L. Abad Effects of atorvastatin on vitamin D levels in patients with acute ischemic heart disease Am J Cardiol 99 2007 903 905
12. L. Rejnmark, P. Vestergaard, Heickendorff, and L. Mosekilde Simvastatin does not affect vitamin D status, but low vitamin D levels are associated with dyslipidemia: results from a randomized, controlled trial Int J Endocrin 2010 957174 2010
13. A.A. Ginde, M.C. Liu, and C.A. Camargo Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004 Arch Intern Med 169 2009 626 632
14. C.F. Garland, E.D. Gorham, S.B. Mohr, and F.C. Garland Vitamin D for cancer prevention: global perspective Ann Epidemiol 19 2009 468 483
15. A.A. Ginde, R. Scragg, R.S. Schwartz, and C.A. Camargo Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults J Am Geriatr Soc 57 2009 1595 1603
16. P. Autier, and S. Gandini Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials Arch Intern Med 167 2007 1730 1737
17. J.M. Lappe, Travers-Gustafson, K.M. Davies, R.R. Recker, and R.P. Heaney Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial Am J Clin Nutr 85 2007 1586 1591
18. K.H. Allin, S.E. Bojesen, and B.G. Nordestgaard Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer J Clin Oncol 27 2009 2217 2224
19. D.T. Ngo, A.L. Sverdlov, J.J. McNeil, and J.D. Horowitz Does vitamin D modulate asymmetric dimethylarginine and C-reactive protein concentrations? Am J Med 123 2010 335 341
20. P.M. Timms, N. Mannan, and G.A. Hitman Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? Q J Med 95 2002 787 796
21. G.A. Nichols, and C.E. Koro Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients Clin Ther 29 2007 1761 1770
22. W. Ahmed, N. Khan, and C.J. Glueck Low serum 25 (OH) vitamin D levels (< 32 ng/ml) are associated with reversible myositis-myalgia in statin-treated patients Transl Res 153 2009 11 16
23. P. Lee, J.R. Greenfield, and L.V. Campbell Vitamin D insufficiency-a novel mechanism of statin induced myalgia? Clin Endocrinol 71 2009 154 155
24. D. Bassler, M. Briel, and V.M. Montori Stopping randomized trials early for benefit and estimation of treatment effects: systemic review and meta-regression analysis JAMA 303 2010 1180 1187
25. J. Shepherd, G.J. Blauw, and M.B. Murphy Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial Lancet 360 2002 1623 1630
26. N.K. Wenger, S.J. Lewis, F.K. Welty, D.M. Herrington, V. Bittner on behalf of the TNT Steering Committee and Investigators Beneficial effects of aggressive low-density lipoprotein cholesterol lowering in women with stable coronary heart disease in the Treating to New Targets (TNT) study Heart 94 2008 434 439
27. M.R. Goldstein, L. Mascitelli, and F. Pezzetta Primary prevention of cardiovascular disease with statins: cautionary notes Q J Med 102 2009 817 820
28. R. Veith Vitamin D toxicity, policy, and science J Bone Miner Res 22 S2 2007 V64 V68
29. E. Liu, J.B. Meigs, and A.G. Pittas Predicted 25-hydroxyvitamin D score and incident type 2 diabetes in the Framingham Offspring Study Am J Clin Nutr Apr 14, 2010 Electronic publication ahead of print
30. L. Mascitelli, F. Pezzetta, and M.R. Goldstein Does intensive cholesterol lowering increase the risk of diabetes? Int J Clin Pract 63 2009 1808
31. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150